Addressing Treatment Resistance in the Development of Cancer Immune Modulator Therapeutics by Forum on Drug Discovery, Development, and Translation, Board on Health Care Services, National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Health Sciences Policy | Lex | Lex
Addressing Treatment Resistance in the Development of Cancer Immune Modulator Therapeutics
Addressing Treatment Resistance in the Development of Cancer Immune Modulator Therapeutics